Hematological Malignancies

Salvage of chemotherapy alone failures (MSKCC) • Progression- 24; relapse- 24 pts. • WBRT- Median- 40 Gy (21-50 Gy) • CR-58%; PR- 21% • 15 pts (31%) remained in remission • Median survival-16 months • 54% survived >1 year • Relapses 33 pts: • Brain- 22 • Spine/lepto-8 • Eyes- 3

47